 |
23 Diseases |  |
12 Trials |
|
12 Trials |  |
1306 News |  |
| «12...3456789101112131415 |
- |||||||||| lurasidone / Generic mfg.
New P3 trial: Lurasidone Extended Use Study (clinicaltrials.gov) - Dec 1, 2011
P3, N=162, Completed, Sponsor: Sunovion
- |||||||||| lurasidone / Generic mfg.
New P3 trial: PEARL Schizophrenia Maintenance (clinicaltrials.gov) - Sep 15, 2011
P3, N=285, Completed, Sponsor: Sunovion
- ||||||| lurasidone / Generic mfg.
Trial completion: SWITCHCore: A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents (clinicaltrials.gov) - Sep 6, 2011
P3, N=244, Completed, Sponsor: Sunovion
Active, not recruiting --> Completed
- ||| lurasidone / Generic mfg.
New P3 trial: RESOLVE3: Major Depressive Disorder With Mixed Features - Extension (clinicaltrials.gov) - Aug 23, 2011
P3, N=48, Completed, Sponsor: Sunovion
- lurasidone / Generic mfg.
New P3 trial: RESOLVE2: Major Depressive Disorder With Mixed Features (clinicaltrials.gov) - Aug 23, 2011
P3, N=0, Withdrawn, Sponsor: Sunovion
- |||||||||| lurasidone / Generic mfg.
New P3 trial: RESOLVE 1: Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose (clinicaltrials.gov) - Aug 18, 2011
P3, N=200, Recruiting, Sponsor: Sunovion
- ||||||| lurasidone / Generic mfg.
Trial completion: PEARL 3 Ext: Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia (clinicaltrials.gov) - Aug 15, 2011
P3, N=240, Completed, Sponsor: Sunovion
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| lurasidone / Generic mfg.
Trial completion: Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia (clinicaltrials.gov) - Aug 15, 2011
P3, N=629, Completed, Sponsor: Sunovion
Active, not recruiting --> Completed Active, not recruiting --> Completed